The discovery of modular binding domains: Building blocks of cell signalling

Nature Reviews Molecular Cell Biology

Volumn 16, Issue 11, 2015, Pages 691-698

  Mayer, Bruce J ^a,b  

^a Raymond and Beverly Sackler Laboratory of Genetics and Molecular Medicine Richard D Berlin Center for Cell Analysis and Modeling   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; PHOSPHOTYROSINE; PROTEIN; PROTEIN SH2; PROTEIN SH3; PROTEIN BINDING;

CELL FUNCTION; CELL SIGNALLING; CELLS; HUMAN; INFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION; CHEMISTRY; LIPID METABOLISM; METABOLISM; MOLECULAR EVOLUTION; SRC HOMOLOGY DOMAIN;

CELLS; EVOLUTION, MOLECULAR; HUMANS; LIPID METABOLISM; PROTEIN BINDING; PROTEINS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS;

EID: 84945436554     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm4068     Document Type: Review

References (94)

1. Cui, Q. & Karplus, M. Allostery and cooperativity revisited. Protein Sci. 17, 1295-1307 (2008).
2. Monod, J., Wyman, J. & Changeux, J. P. On the nature of allosteric transitions: a plausible model. J. Mol. Biol. 12, 88-118 (1965).
3. Bourne, H. R. Signals past, present, and future. Cold Spring Harb. Symp. Quant. Biol. 53, 1019-1031 (1988).
4. Eckhart, W., Hutchinson, M. A. & Hunter, T. An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates. Cell 18, 925-933 (1979).
5. Hunter, T. & Sefton, B. M. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl Acad. Sci. USA 77, 1311-1315 (1980).
6. Ebina, Y. et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 40, 747-758 (1985).
7. Ullrich, A. et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313, 756-761 (1985).
8. Ullrich, A. et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309, 418-425 (1984).
9. Downward, J. et al. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307, 521-527 (1984).
10. Iba, H., Cross, F. R., Garber, E. A. & Hanafusa, H. Low level of cellular protein phosphorylation by nontransforming overproduced p60c-src. Mol. Cell. Biol. 5, 1058-1066 (1985).
11. Coussens, P. M., Cooper, J. A., Hunter, T. & Shalloway, D. Restriction of the in vitro and in vivo tyrosine protein kinase activities of pp60c-src relative to pp60v-src. Mol. Cell. Biol. 5, 2753-2763 (1985).
12. Brugge, J. S. & Darrow, D. Analysis of the catalytic domain of phosphotransferase activity of two avian sarcoma virus-transforming proteins. J. Biol. Chem. 259, 4550-4557 (1984).
13. Levinson, A. D., Courtneidge, S. A. & Bishop, J. M. Structural and functional domains of the Rous sarcoma virus transforming protein (pp60src). Proc. Natl Acad. Sci. USA 78, 1624-1628 (1981).
14. Bryant, D. & Parsons, J. T. Site-directed mutagenesis of the src gene of Rous sarcoma virus: construction and characterization of a deletion mutant temperature sensitive for transformation. J. Virol. 44, 683-691 (1982).
15. DeClue, J. E. & Martin, G. S. Linker insertion-deletion mutagenesis of the v-src gene: isolation of host-and temperature-dependent mutants. J. Virol. 63, 542-554 (1989).
16. DeClue, J. E., Sadowski, I., Martin, G. S. & Pawson, T. A conserved domain regulates interactions of the v-fps protein-tyrosine kinase with the host cell. Proc. Natl Acad. Sci. USA 84, 9064-9068 (1987).
17. v-src restricts transformation in a host-dependent manner. J. Virol. 63, 338-348 (1989).
18. Iwashita, S., Kitamura, N. & Yoshida, M. Molecular events leading to fusiform morphological transformation by partial src deletion mutant of Rous sarcoma virus. Virology 125, 419-431 (1983).
19. gag-fps. Mol. Cell. Biol. 6, 4396-4408 (1986).
20. Glenney, J. R., Zokas, L. & Kamps, M. P. Monoclonal antibodies to phosphotyrosine. J. Immunol. Methods 109, 277-285 (1988).
21. Frackelton, A. R. J., Ross, A. H. & Eisen, H. N. Characterization and use of monoclonal antibodies for isolation of phosphotyrosyl proteins from retrovirus-transformed cells and growth factor-stimulated cells. Mol. Cell. Biol. 3, 1343-1352 (1983).
22. Kaplan, D. R., Morrison, D. K., Wong, G., McKormick, F. & Williams, L. T. PDGF β-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with signalling complex. Cell 61, 125-133 (1990).
23. Kazlauskas, A. & Cooper, J. Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell 58, 1121-1133 (1989).
24. Meisenhelder, J., Suh, P.-G., Rhee, S. G. & Hunter, T. Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro. Cell 57, 1109-1122 (1989).
25. Margolis, B. et al. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell 57, 1101-1107 (1989).
26. Mayer, B. J., Hamaguchi, M. & Hanafusa, H. A novel viral oncogene with structural similarity to phospholipase C. Nature 332, 272-275 (1988).
27. Stahl, M. L., Ferenz, C. R., Kelleher, K. L., Kriz, R. W. & Knopf, J. L. Sequence similarity of phospholipase C with the non-catalytic region of src. Nature 332, 269-272 (1988).
28. Trahey, M. et al. Molecular cloning of two types of GAP cDNA from human placenta. Science 242, 1697-1700 (1988).
29. g1, GAP, and src to activated growth factor receptors. Science 250, 979-982 (1990).
30. Margolis, B. et al. The tyrosine-phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC-γ. EMBO J. 9, 4375-4380 (1990).
31. Matsuda, M., Mayer, B. J. & Hanafusa, H. Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins. Mol. Cell. Biol. 11, 1607-1613 (1991).
32. Mayer, B. J., Jackson, P. K. & Baltimore, D. The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. Proc. Natl Acad. Sci. USA 88, 627-631 (1991).
33. Moran, M. F. et al. Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc. Natl Acad. Sci. USA 87, 8622-8626 (1990).
34. lck. Nature 362, 87-91 (1993).
35. Waksman, G. et al. Crystal structure of the phosphotyrosine recognition domain (SH2) of the v-src tyrosine kinase complexed with tyrosine phosphorylated peptides. Nature 358, 646-653 (1992).
36. Waksman, G., Shoelson, S. E., Pant, N., Cowburn, D. & Kuriyan, D. Binding of a high affinity phosphotyrosyl psptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell 72, 779-790 (1993).
37. Songyang, Z. et al. SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778 (1993).
38. Songyang, Z. et al. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14, 2777-2785 (1994).
39. Overduin, M., Rios, C. B., Mayer, B. J., Baltimore, D. & Cowburn, D. Three dimensional solution structure of the src homology 2 domain of c-abl. Cell 70, 697-704 (1992).
40. Liu, B. A. et al. The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Mol. Cell 22, 851-868 (2006).
41. Seet, B. T., Dikic, I., Zhou, M. M. & Pawson, T. Reading protein modifications with interaction domains. Nat. Rev. Mol. Cell Biol. 7, 473-483 (2006).
42. Komander, D. & Rape, M. The ubiquitin code. Annu. Rev. Biochem. 81, 203-229 (2012).
43. Dikic, I., Wakatsuki, S. & Walters, K. J. Ubiquitin-binding domains-from structures to functions. Nat. Rev. Mol. Cell Biol. 10, 659-671 (2009).
44. Jenuwein, T. & Allis, C. D. Translating the histone code. Science 293, 1074-1080 (2001).
45. Harlan, J. E., Hajduk, P. J., Yoon, H. S. & Fesik, S. W. Pleckstrin homology domains bind to phosphatidylinositol-4, 5-bisphosphate. Nature 371, 168-170 (1994).
46. Lemmon, M. A., Ferguson, K. M., Sigler, P. B. & Schlessinger, J. Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain. Proc. Natl Acad. Sci. USA 92, 10472-10476 (1995).
47. Yu, J. W. et al. Genome-wide analysis of membrane targeting by S. cerevisiae pleckstrin homology domains. Mol. Cell 13, 677-688 (2004).
48. Park, W. S. et al. Comprehensive identification of PIP3-regulated PH domains from C. elegans to H. sapiens by model prediction and live imaging. Mol. Cell 30, 381-392 (2008).
49. Gallego, O. et al. A systematic screen for protein-lipid interactions in Saccharomyces cerevisiae. Mol. Syst. Biol. 6, 430 (2010).
50. Cicchetti, P., Mayer, B. J., Thiel, G. & Baltimore, D. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257, 803-806 (1992).
51. Ren, R., Mayer, B. J., Cicchetti, P. & Baltimore, D. Identification of a 10-amino acid proline-rich SH3 binding site. Science 259, 1157-1161 (1993).
52. Kay, B. K., Williamson, M. P. & Sudol, M. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 14, 231-241 (2000).
53. Zarrinpar, A., Bhattacharyya, R. P. & Lim, W. A. The structure and function of proline recognition domains. Sci. STKE 2003, RE8 (2003).
54. Kärkkäinen, S. et al. Identification of preferred protein interactions by phage-display of the human Src homology-3 proteome. EMBO Rep. 7, 186-191 (2006).
55. Feng, S., Chen, J. K., Yu, H., Simon, J. A. & Schreiber, S. L. Tw o binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 266, 1241-1247 (1994).
56. Lim, W. A., Richards, F. M. & Fox, R. O. Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature 372, 375-379 (1994).
57. Kennedy, M. B. Origin of PDZ (DHR, GLGF) domains. Trends Biochem. Sci. 20, 350 (1995).
58. Ponting, C. P. & Phillips, C. DHR domains in syntrophins, neuronal NO synthases and other intracellular proteins. Trends Biochem. Sci. 20, 102-103 (1995).
59. Sheng, M. & Sala, C. PDZ domains and the organization of supramolecular complexes. Annu. Rev. Neurosci. 24, 1-29 (2001).
60. Rubin, G. M. Signal transduction and the fate of the R7 photoreceptor in Drosophila. Trends Genet. 7, 372-377 (1990).
61. Horvitz, H. R. & Sternberg, P. W. Multiple intercellular signalling systems control the development of the Caenorhabditis elegans vulva. Nature 351, 535-541 (1991).
62. Clark, S. G., Stern, M. J. & Horvitz, H. R. C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature 356, 340-344 (1992).
63. Bonfini, L., Karlovich, C. A., Dasgupta, C. & Bannerjee, U. The Son of sevenless gene product: a putative activator of Ras. Science 255, 603-606 (1992).
64. Simon, M. A., Bowtell, D. D., Dodson, G. S., Laverty, T. R. & Rubin, G. M. Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase. Cell 67, 701-716 (1991).
65. Cox, A. D. & Der, C. J. Ras history: the saga continues. Small GTPases 1, 2-27 (2010).
66. McCormick, F. How receptors turn Ras on. Nature 363, 15-16 (1993).
67. Aronheim, A. et al. Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell 78, 949-961 (1994).
68. Quilliam, L. A. et al. Membrane-targeting potentiates guanine nucleotide exchange factor CDC25 and SOS1 activation of Ras transforming activity. Proc. Natl Acad. Sci. USA 91, 8512-8516 (1994).
69. Cheng, A. M. et al. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 95, 793-803 (1998).
70. Sicheri, F., Moarefi, I. & Kuriyan, J. Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609 (1997).
71. Xu, W., Harrison, S. C. & Eck, M. J. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602 (1997).
72. Lim, W. A. The modular logic of signaling proteins: building allosteric switches from simple binding domains. Curr. Opin. Struct. Biol. 12, 61-68 (2002).
73. Dueber, J. E., Yeh, B. J., Chak, K. & Lim, W. A. Reprogramming control of an allosteric signaling switch through modular recombination. Science 301, 1904-1908 (2003).
74. Pawson, T. & Nash, P. Assembly of cell regulatory systems through protein interaction domains. Science 300, 445-452 (2003).
75. Mayer, B. J., Blinov, M. L. & Loew, L. M. Molecular machines or pleiomorphic ensembles: signaling complexes revisited. J. Biol. 8, 81 (2009).
76. Gibson, T. J. Cell regulation: determined to signal discrete cooperation. Trends Biochem. Sci. 34, 471-482 (2009).
77. Li, P. et al. Phase transitions in the assembly of multi-valent signaling proteins. Nature 483, 336-340 (2012).
78. Toomre, D. & Bewersdorf, J. A new wave of cellular imaging. Annu. Rev. Cell Dev. Biol. 26, 285-314 (2010).
79. Zhou, X., Herbst-Robinson, K. J. & Zhang, J. Visualizing dynamic activities of signaling enzymes using genetically encodable FRET-based biosensors from designs to applications. Methods Enzymol. 504, 317-340 (2012).
80. Findlay, G. M. et al. Interaction domains of Sos1/Grb2 are finely tuned for cooperative control of embryonic stem cell fate. Cell 152, 1008-1020 (2013).
81. Zheng, Y. et al. Temporal regulation of EGF signalling networks by the scaffold protein Shc1. Nature 499, 166-171 (2013).
82. Jadwin, J. A., Ogiue-Ikeda, M. & Machida, K. The application of modular protein domains in proteomics. FEBS Lett. 586, 2586-2596 (2012).
83. Hu, H. et al. A map of WW domain family interactions. Proteomics 4, 643-655 (2004).
84. Hesselberth, J. R. et al. Comparative analysis of Saccharomyces cerevisiae WW domains and their interacting proteins. Genome Biol. 7, R30 (2006).
85. Huang, H. et al. Defining the specificity space of the human SRC homology 2 domain. Mol. Cell. Proteomics 7, 768-784 (2008).
86. Jones, R. B., Gordus, A., Krall, J. A. & MacBeath, G. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439, 168-174 (2006).
87. Stiffler, M. A. et al. PDZ domain binding selectivity is optimized across the mouse proteome. Science 317, 364-369 (2007).
88. Tinti, M. et al. The human SH2 interaction landscape. Cell Rep. 3, 1293-1305 (2013).
89. Tonikian, R. et al. Bayesian modeling of the yeast SH3 domain interactome predicts spatiotemporal dynamics of endocytosis proteins. PLoS Biol. 7, e1000218 (2009).
90. Tonikian, R. et al. A specificity map for the PDZ domain family. PLoS Biol. 6, 239 (2008).
91. Schneider, T. D. & Stephens, R. M. Sequence logos: a new way to display consensus sequences. Nucleic Acids Res. 18, 6097-6100 (1990).
92. Czernilofsky, A. P. et al. Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed amino acid sequence for gene product. Nature 287, 198-203 (1980).
93. Muslin, A. J., Tanner, J. W., Allen, P. M. & Shaw, A. S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84, 889-897 (1996).
94. Yaffe, M. B. et al. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91, 961-971 (1997).